Hamburg Outlines Planned Reforms Of FDA Criminal Investigations Office

FDA Commissioner Margaret Hamburg outlined reforms planned for the agency's Office of Criminal Investigations, including new criteria for selecting misdemeanor prosecution cases against responsible corporate officials

More from Archive

More from Medtech Insight